Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis - PubMed (original) (raw)
Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis
Liza Suh et al. Pediatr Dermatol. 2008 Sep-Oct.
Abstract
Children with atopic dermatitis are more frequently colonized with Staphylococcus aureus than children without atopic dermatitis. However, little epidemiological data exist regarding the prevalence of methicillin-resistant S. aureus among children with atopic dermatitis. Recent studies have revealed an increasing prevalence of community-associated methicillin-resistant S. aureus among patients presenting to hospitals with serious bacterial infections, particularly those with cutaneous and soft tissue infections. As many atopic dermatitis patients are treated empirically with antibiotics for secondary skin infections, an understanding of the epidemiology of bacterial colonization and superinfection is essential for directing proper treatment in the atopic patient population. This study investigates the prevalence of risk factors for community-associated, methicillin-resistant S. aureus colonization among pediatric atopic dermatitis patients encountered at an academic pediatric dermatology clinic. An observational cross-sectional study was conducted at the Children's Hospital of Philadelphia in which 54 patients previously diagnosed with atopic dermatitis were enrolled. A detailed patient questionnaire, a complete cutaneous examination, and an evaluation of eczema severity according to the Eczema Area and Severity Index were completed at the time of enrollment. Bacterial cultures from the skin and nares were obtained to determine the frequency of colonization with either methicillin-sensitive S. aureus or methicillin-resistant S. aureus. Although most atopic dermatitis patients studied were colonized with S. aureus (43/54 [80%]), methicillin-resistant S. aureus was isolated from only seven atopic dermatitis patients (7/43 [16%]). Patients colonized with S. aureus were more likely to be male, to have been previously hospitalized, to have used a topical calcineurin inhibitor in combination with a topical steroid, and less likely to have used topical antibiotics. Bivariable analysis, however, revealed that only previous hospitalization was independently associated with an increased risk of methicillin-resistant S. aureus colonization. We observed that 80% of atopic dermatitis patients were colonized with S. aureus, and that of these patients, 16% of colonized patients were colonized with a methicillin-resistant strain. Methicillin-resistant S. aureus colonization was found to be significantly associated with previous hospitalization. Evidence also indicates that topical calcineurin inhibitors used in conjunction with topical steroids is associated with increased S. aureus colonization, while topical antibiotic use appears to decrease S. aureus colonization.
Similar articles
- Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.
Matiz C, Tom WL, Eichenfield LF, Pong A, Friedlander SF. Matiz C, et al. Pediatr Dermatol. 2011 Jan-Feb;28(1):6-11. doi: 10.1111/j.1525-1470.2010.01293.x. Epub 2010 Nov 11. Pediatr Dermatol. 2011. PMID: 21070347 - Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.
Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Huang JT, et al. Pediatrics. 2009 May;123(5):e808-14. doi: 10.1542/peds.2008-2217. Pediatrics. 2009. PMID: 19403473 Clinical Trial. - Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B. Gong JQ, et al. Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x. Br J Dermatol. 2006. PMID: 16965415 Clinical Trial. - Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis.
Stone A, Saiman L. Stone A, et al. Curr Opin Pulm Med. 2007 Nov;13(6):515-21. doi: 10.1097/MCP.0b013e3282efbbac. Curr Opin Pulm Med. 2007. PMID: 17901758 Review. - Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management.
Paintsil E. Paintsil E. Curr Opin Pediatr. 2007 Feb;19(1):75-82. doi: 10.1097/MOP.0b013e32801261c9. Curr Opin Pediatr. 2007. PMID: 17224666 Review.
Cited by
- Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Elizalde-Jiménez IG, Ruiz-Hernández FG, Carmona-Cruz SA, Pastrana-Arellano E, Aquino-Andrade A, Romo-González C, Arias-de la Garza E, Álvarez-Villalobos NA, García-Romero MT. Elizalde-Jiménez IG, et al. JAMA Dermatol. 2024 Sep 25:e243360. doi: 10.1001/jamadermatol.2024.3360. Online ahead of print. JAMA Dermatol. 2024. PMID: 39320869 - Association Between Staphylococcus Aureus Colonization and Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Sangaphunchai P, Kritsanaviparkporn C, Treesirichod A. Sangaphunchai P, et al. Indian J Dermatol. 2023 Nov-Dec;68(6):619-627. doi: 10.4103/ijd.ijd_453_22. Epub 2024 Jan 9. Indian J Dermatol. 2023. PMID: 38371569 Free PMC article. - Atopic dermatitis pediatric patients show high rates of nasal and intestinal colonization by methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci.
Augusto de Oliveira MF, Agne DB, Bastos LSS, Andrade de Oliveira LM, Saintive S, Goudouris ES, do Prado EA, Fragoso Dos Santos H, da Silva Pereira R, Cavalcante FS, de Carvalho Ferreira D, Dos Santos KRN. Augusto de Oliveira MF, et al. BMC Microbiol. 2024 Jan 29;24(1):42. doi: 10.1186/s12866-023-03165-5. BMC Microbiol. 2024. PMID: 38287251 Free PMC article. - Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.
Weiss A, Delavenne E, Matias C, Lagler H, Simon D, Li P, Hansen JU, Dos Santos TP, Jana B, Priemel P, Bangert C, Bauer M, Eberl S, Nussbaumer-Pröll A, Anne Österreicher Z, Matzneller P, Quint T, Weber M, Nielsen HM, Rades T, Johansen HK, Westh H, Kim W, Mylonakis E, Friis C, Guardabassi L, Pace J, Lundberg CV, M'Zali F, Butty P, Sørensen N, Nielsen HB, Toft-Kehler R, Guttman-Yassky E, Stingl G, Zeitlinger M, Sommer M. Weiss A, et al. Clin Transl Med. 2022 May;12(5):e790. doi: 10.1002/ctm2.790. Clin Transl Med. 2022. PMID: 35522900 Free PMC article. Clinical Trial. - Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from Patients with Atopic Dermatitis.
Shimamori Y, Pramono AK, Kitao T, Suzuki T, Aizawa SI, Kubori T, Nagai H, Takeda S, Ando H. Shimamori Y, et al. Curr Microbiol. 2021 Apr;78(4):1267-1276. doi: 10.1007/s00284-021-02395-y. Epub 2021 Feb 26. Curr Microbiol. 2021. PMID: 33638001 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials